Thus, we show that ITPP is a promising agent that could prevent progression of heart failure and that its effect may go beyond simple improvement of oxygen delivery to ischaemic tissues, namely involve prevention of HIF‐1 overexpression and presumably its detrimental effects. Here, TPP1 is linked to heart failure.